|
Written by Site Editor
|
|
Wednesday, 24 October 2007 00:00 |
International HHT Conference, Capri, 2007. Yale Team Abstracts:
1. OUTCOMES OF SYMPTOMATIC LIVER VASCULAR MALFORMATIONS IN HEREDITARY HEMORRHAGIC TELANGIECTASIA.
LH Young, I Jovin, KJ Henderson, *D Chyun, G Garcia-Tsao, RI White Jr., Yale University School of Medicine and *Yale University School of Nursing, New Haven, CT, USA
2. NEW CLASSIFICATION AND NATURAL HISTORY OF PATIENTS WITH DIFFUSE PULMONARY ARTERIOVENOUS MALFORMATIONS: 29 YEAR EXPERIENCE. P Pierucci, J Murphy, K Henderson, JT Fahey, *D Chyun, RI White Jr., Yale University School of Medicine and *Yale University School of Nursing, New Haven, CT, USA
3. DESCRIPTION AND PRELIMINARY RESULTS OF A NEW EXERCISE STRESS TEST FOR MEASURING FUNCTIONAL CAPACITY OF PATIENTS WITH DIFFUSE PULMONARY ARTERIOVENOUS MALFORMATIONS. JJ Murphy, P Pierucci, K Henderson, JT Fahey, *D Chyun, RI White Jr., Yale University School of Medicine and *Yale University School of Nursing, New Haven, Connecticut, USA
4. LONG TERM COMPLICATIONS OF SEPTAL DERMOPLASTY IN HEREDITARY HAEMORRHAGIC TELANGIECTASIA PATIENTS. C Levine, K Henderson, SB Leder, RI White, DA Ross, Section of Otolaryngology (CL,SBL,DAR), Department of Radiology (KH,RIW), and The Yale Vascular Malformation Center (CL,DAR,KH,RIW), Yale University School of Medicine, New Haven, Connecticut, USA
International HHT Conference, Lyon, 2005. Yale Team Abstracts:
1. CLINICAL AND ANATOMICAL OUTCOME AFTER PULMONARY ARTERIOVENOUS MALFORMATION EMBOLOTHERAPY. JS Pollak, A Thabet, S Saluja, KJ Henderson, N Debow, RI White Jr. Department of Diagnostic Radiology, Section of Interventional Radiology, Yale University School of Medicine, New Haven, CT, USA
2. OUTCOME OF SEPTAL DERMOPLASTY IN PATIENTS WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA. ML Fiorella*, D Ross**, KJ Henderson***, RI White Jr.*** *Department Otolaryngology, University of Bari, Bari, Italy, **Department of Surgery, Section of Otolaryngology, Yale University School of Medicine, New Haven, CT, USA, *** Department of Diagnostic Radiology, Section of Interventional Radiology, Yale University School of Medicine, New Haven, CT, USA
3. LONG TERM OUTCOMES IN PATIENTS WITH SYMPTOMATIC LIVER HEREDITARY HEMORRHAGIC TELANGIECTASIA. L Young*, G Garcia-Tsao*, KJ Henderson**, S Saluja**, Ion Jovin*, HM Thorisson**, RI White Jr.** *Department of Internal Medicine, **Department of Radiology, Yale University School of Medicine, New Haven, CT, USA
International HHT Conference, Bonaire, 2003. Yale Team Abstracts:
1. MULTIPHASE CT IN THE EVALUATION OF SYMPTOMATIC LIVER DISEASE IN PATIENTS WITH HHT. Saluja S, Wu J, Chong A, Byrd B, Henderson KJ, Garcia-Tsao G, White RI
2. ARE ENDOSCOPIC FINDINGS IN THE STOMACH AND DUODENUM PREDICTIVE OF FINDINGS IN THE JEJUNUM IN PATIENTS WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA?. DD Proctor, KJ Henderson, A Longacre, RI White.
3. FATAL LUNG HEMORRHAGE ASSOCIATED WITH PULMONARY ARTERIOVENOUS MALFORMATIONS IN CHILDREN. O'Donoghue P 1, Thabet A2, Brady A1, Colwell N1, Burke L3, Henderson K2, Gallione C4, Marchuk D4, White RI2. 1 HHT Center Mercy University Hospital, Cork, Ireland, 2Yale University School of Medicine, New Haven, CT, 3University College Cork, Cork, Ireland, 4Duke University, Durham, NC
4. A CASE SERIES: THE DIAGNOSIS OF GASTROINTESTINAL BLEEDING AND RESPONSE TO MEDICAL MANAGEMENT IN PATIENTS WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA. Anna V. Longacre, M.D., Cary P. Gross, M.D., Mauro Gallitelli, M.D., Katharine J. Henderson, M.S., Robert I. White, Jr., M.D., Deborah D. Proctor, M.D.
5. HEART FAILURE AND PULMONARY HYPERTENSION IN PATIENTS WITH HEPATIC AVM AND HHT. Lawrence H Young, Ion S Jovin, Guadalupe Garcia-Tsao, Katharine J Henderson, Robert I White.
6. ANEURYSMAL "SAC" INVOLUTION: A CRITICAL DETERMINANT OF OUTCOME AFTER EMBOLOTHERAPY OF PULMONARY AVM. S, Pollak JS, Thabet A, Henderson KJ, Denbow N, White RI
International HHT Conference, Canary Islands, 2001. Yale Team Abstracts:
1. The Yale multidiscipline HHT center: a 5-year experience. RI White, Jr., KJ Henderson
2. Aneurysmal "sac" involution, a critical determinant of outcome after emboltherapy of pulmonary arteriovenous malformation (PAVM). RI White, Jr., S Saluja, J Pollak, B Byrd, KJ Henderson.
3. Does the number and/or distribution of arteriovenous malformations change in patients with Hereditary Hemorrhagic Teleangiectasia? DD Proctor, J Price, KJ Henderson, RI White.
4. Liver Involvement in Hereditary Hemorrhagic Teleangiectasia (HHT) - an update on outcome. G Garcia-Tsao, KJ Henderson, L Young, B Byrd, D Proctor, JS Pollak, RI White.
5. Musculosceletal and liver infections associated with pulmonary arteriovenous malformations. KJ Henderson, S Saluja, B Byrd, RI White, Jr.
05/31/2002 HHT Glossary: AVM definiton
06/03/2002 YALE AVM Center Outreach
1. AVM Center Mission
2. Japanese Outreach
3. Genetic Alliance Award 2005
|
|
Last Updated ( Sunday, 09 March 2008 23:35 )
|
Copyright © 2010 Yale University AVM Center. All Rights Reserved.
|
Conferences
